Corcept Therapeutics, Inc. (CORT)

35.07 -0.63 (-1.76%) USD  |  NASDAQ  |  Mar 02, 11:16
More

Corcept Therapeutics Quarterly Revenue Estimates

Quarterly Revenue Estimates Chart

View Quarterly Revenue Estimates for CORT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Revenue Estimates Range, Past 5 Years

View Quarterly Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Revenue Estimates Benchmarks

View Quarterly Revenue Estimates Benchmarks
Start Trial
Axsome Therapeutics, Inc. Upgrade
United Therapeutics Corp. Upgrade
Harrow, Inc. Upgrade
Ultragenyx Pharmaceutical, Inc. Upgrade
Amneal Pharmaceuticals, Inc. Upgrade